Inj, rimabotulinumtoxinb
Products billed under this code include Myobloc.
Payment limit per 100 UNITS, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Myobloc.
Payment limit per 100 UNITS, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Myobloc | Supernus Pharmaceuticals, Inc. | 10454-0710-10 | 25 | $332.525 |
| Myobloc | Supernus Pharmaceuticals, Inc. | 10454-0711-10 | 50 | $665.05 |
| Myobloc | Supernus Pharmaceuticals, Inc. | 10454-0712-10 | 100 | $1,330.10 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $13.301 | +$0.014 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted September 17, 2026 |
| 3Q26 | $13.287 | +$0.004 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted September 15, 2026 |
| 2Q26 | $13.283 | −$0.006 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted September 15, 2026 |
| 1Q26 | $13.289 | +$0.001 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted September 15, 2026 |
| 4Q25 | $13.288 | −$0.055 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted September 8, 2026 |
| 3Q25 | $13.343 | +$0.347 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted March 10, 2026 |
| 2Q25 | $12.996 | +$0.005 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted March 10, 2026 |
| 1Q25 | $12.991 | +$0.002 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted December 19, 2025 |
| 4Q24 | $12.989 | −$0.074 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted June 11, 2025 |
| 3Q24 | $13.063 | +$0.028 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted June 11, 2025 |
| 2Q24 | $13.035 | +$0.009 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted March 11, 2025 |
| 1Q24 | $13.026 | −$0.016 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted December 19, 2024 |
| 4Q23 | $13.042 | +$0.321 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted October 10, 2024 |
| 3Q23 | $12.721 | +$0.021 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted June 5, 2024 |
| 2Q23 | $12.70 | +$0.225 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted February 23, 2024 |
| 1Q23 | $12.475 | +$0.002 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted December 6, 2023 |
| 4Q22 | $12.473 | +$0.301 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted June 22, 2023 |
| 3Q22 | $12.172 | +$0.001 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted June 9, 2023 |
| 2Q22 | $12.171 | +$0.048 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted December 14, 2022 |
| 1Q22 | $12.123 | +$0.071 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted June 8, 2022 |
| 4Q21 | $12.052 | +$0.029 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted June 2, 2022 |
| 3Q21 | $12.023 | +$0.052 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted June 2, 2022 |
| 2Q21 | $11.971 | +$0.004 | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted March 1, 2022 |
| 1Q21 | $11.967 | – | 100 UNITS | Inj, rimabotulinumtoxinb | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.